Selkirk Pharma Inc., a privately held U.S. pharmaceutical manufacturer specializing in the fill and finish of injectable drugs, has announced the Aseptic Process Simulation (APS) qualification of its sterile manufacturing facility and newly available fill/finish capacity.   This development marks a milestone for the company in addressing industry bottlenecks and lack of U.S.-based manufacturing capacity, while offering clinical and commercial manufacturing services for small molecule and biolo...